Is Persistent Cough Affecting Your Quality of Life?

Exploring Chronic Cough in Participants with Idiopathic Pulmonary Fibrosis Clinical Trials

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by scarring (fibrosis) of lung tissue. One of its common and challenging symptoms is persistent coughing, which can interfere with everyday activities, sleep, social interactions, and overall quality of life.

Chronic cough affects a substantial number of individuals living with IPF. Despite available treatments that may help slow the progression of lung scarring, persistent cough remains an important symptom that requires further research.

Revive Research Institute is providing information about chronic cough in participants with idiopathic pulmonary fibrosis clinical trials in Michigan. This clinical research study is designed to evaluate the safety and efficacy of an investigational treatment, for managing chronic cough associated with IPF.

If you have been diagnosed with idiopathic pulmonary fibrosis and experience persistent coughing, participating in clinical research may provide an opportunity to contribute to the scientific understanding of IPF-related cough and the evaluation of potential treatment approaches.

You May Qualify for Chronic Cough Clinical Trials If You:

  • Are ≥40 years of age.
  • Have a confirmed diagnosis of idiopathic pulmonary fibrosis (IPF).

*Additional eligibility criteria apply.

*If you would like to learn more about chronic cough in participants with idiopathic pulmonary fibrosis clinical trials, complete the form to share your contact information. A member of the research team can contact you to discuss the study and determine whether you may qualify through an initial screening process. Participation is entirely voluntary.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
For more info, please visit Privacy Policy.
Chronic Cough in Participants with Idiopathic Pulmonary Fibrosis Clinical Trials Flyer

About Chronic Cough in Participants with Idiopathic Pulmonary Fibrosis Clinical Trials in Michigan

This study is designed to evaluate the safety and efficacy of potential treatment option for the treatment of chronic cough in participants diagnosed with idiopathic pulmonary fibrosis.

Eligible participants will be randomly assigned to receive either the investigational treatment or a matching placebo. Neither participants nor the study team will know which treatment has been assigned during the blinded portion of the study.

Researchers will evaluate changes in cough frequency using an objective 24-hour cough monitoring device. The study will also assess cough severity, respiratory symptoms, and participants’ reported quality of life.

*Study-related procedures and visits may be provided at no cost to eligible participants. Please speak with the study team for details.

What You Can Expect

Has persistent coughing associated with idiopathic pulmonary fibrosis been affecting your daily routine, sleep, or overall comfort?

If you are interested in participating in chronic cough in participants with idiopathic pulmonary fibrosis clinical trials, the first step is to complete the contact form on this page. A member of the research team will contact you to discuss your interest and conduct an initial pre-screening to determine whether you may meet the study’s basic eligibility requirements.

If you meet the initial study requirements, the research team will provide detailed information about the study and explain the informed consent process. You will have an opportunity to ask questions and review the study information before making your decision.

If you decide to participate, you will be asked to sign an Informed Consent Form (ICF). After providing informed consent, you may be invited to a screening visit at the clinical research site.

Age

Are ≥40 years of age

Cobdition

Chronic Cough Associated with Idiopathic Pulmonary Fibrosis (IPF)

Location

Michigan

About Idiopathic Pulmonary Fibrosis and Chronic Cough Symptoms

Chronic Cough in Participants with Idiopathic Pulmonary Fibrosis Clinical Trials
Idiopathic pulmonary fibrosis is a progressive fibrosing interstitial lung disease that causes scar tissue to develop in the lungs. As fibrosis progresses, the lungs can become increasingly stiff, making it more difficult for oxygen to move into the bloodstream.

Chronic cough is a common symptom among individuals living with IPF. It may persist even when patients are receiving treatment intended to slow the progression of lung fibrosis.

Factors and Conditions Associated with IPF-Related Chronic Cough

  • Age
  • Lung tissue scarring
  • Airway distortion
  • Airway hypersensitivity
  • Respiratory impairment

Common Symptoms Associated with Idiopathic Pulmonary Fibrosis

  • Persistent Dry Cough
  • Shortness of Breath
  • Reduced Exercise Tolerance
  • Fatigue
  • Respiratory Discomfort

Frequently Asked Questions (FAQs)

Chronic cough in idiopathic pulmonary fibrosis (IPF) is a persistent respiratory symptom experienced by many individuals diagnosed with this progressive lung disease. It may continue over an extended period and significantly affect sleep, physical activities, social interactions, and quality of life.

The study includes adults aged 40 years and older who have a confirmed diagnosis of IPF and a history of chronic cough lasting at least 8 weeks before screening.

These clinical trials evaluate investigational treatment approaches for persistent coughing associated with idiopathic pulmonary fibrosis.

Yes. Participation in clinical research is entirely voluntary. Before joining, the research team will explain the study’s purpose, procedures, potential risks, and requirements. Participants can ask questions and review the informed consent information before deciding whether to participate.